SCHEMBL28234596

SCHEMBL28234596

CC(C)[C@H](N)C(=O)NC(CCCNC(N)=O)C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.42
▸ DPP8 Q6V1X1 2/20 0.42
▸ DPP9 Q86TI2 2/20 0.42
▸ DPP7 Q9UHL4 2/20 0.42
▸ NOD1 Q9Y239 1/20 0.41
▸ SIRT5 Q9NXA8 2/20 0.41
▸ FAP Q12884 1/20 0.40
▸ NPY4R P50391 7/20 0.38
▸ NPY1R P25929 5/20 0.38
▸ NPY2R P49146 4/20 0.38
▸ NPY5R Q15761 4/20 0.38
▸ C3AR1 Q16581 1/20 0.36
▸ ECE1 P42892 1/20 0.35
▸ KISS1R Q969F8 1/20 0.35
▸ ALB P02768 1/20 0.34
▸ TLR2 O60603 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20795868 1.00 DPP4 (0.42) DPP4DPP8DPP9DPP7NOD1
SCHEMBL22848364 1.00 DPP4 (0.42) DPP4DPP8DPP9DPP7NOD1
SCHEMBL22797764 1.00 DPP4 (0.42) DPP4DPP8DPP9DPP7NOD1
SCHEMBL25448049 0.93 DPP7 (0.41) DPP4DPP8DPP9DPP7NOD1
SCHEMBL14887421 0.93 DPP7 (0.41) DPP4DPP8DPP9DPP7NOD1
SCHEMBL16645050 0.93 DPP7 (0.41) DPP4DPP8DPP9DPP7NOD1
SCHEMBL29359380 0.90 C3AR1 (0.46) DPP4DPP8DPP9DPP7NOD1
SCHEMBL6047671 0.90 C3AR1 (0.46) DPP4DPP8DPP9DPP7NOD1
SCHEMBL16862522 0.90 C3AR1 (0.46) DPP4DPP8DPP9DPP7NOD1
SCHEMBL28819908 0.90 C3AR1 (0.46) DPP4DPP8DPP9DPP7NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110152014-A Anti- TRAILR2 Antibody-toxin-conjugate and its medicinal usage in antineoplaston 和元生物技术(上海)股份有限公司 2019-08-23 — — CN claimed
CN-108452320-A Anti- TRAILR2 Antibody-toxins-conjugate and its medicinal usage in antineoplaston 和元生物技术(上海)股份有限公司 2018-08-28 — — CN claimed
Send feedback